Sumitomo Mitsui Trust Group
TDOC icon

Sumitomo Mitsui Trust Group’s Teladoc Health TDOC Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,136,936
Closed -$40.5M – 1101
2024
Q2 		$40.5M Sell
4,136,936
-3,044,752
-42% -$37.1M 0.03% 482
2024
Q1 		$108M Sell
7,181,688
-292,986
-4% -$5.32M 0.07% 277
2023
Q4 		$161M Sell
7,474,674
-212,972
-3% -$3.93M 0.12% 180
2023
Q3 		$143M Sell
7,687,646
-181,228
-2% -$4.23M 0.12% 182
2023
Q2 		$199M Sell
7,868,874
-164,914
-2% -$4.15M 0.16% 140
2023
Q1 		$208M Sell
8,033,788
-91,443
-1% -$2.45M 0.16% 144
2022
Q4 		$192M Sell
8,125,231
-474,272
-6% -$12.8M 0.15% 150
2022
Q3 		$218M Sell
8,599,503
-123,004
-1% -$4.32M 0.18% 122
2022
Q2 		$290M Sell
8,722,507
-120,302
-1% -$5.11M 0.22% 95
2022
Q1 		$638M Sell
8,842,809
-297,999
-3% -$21.5M 0.42% 44
2021
Q4 		$839M Buy
9,140,808
+1,336,508
+17% +$160M 0.51% 32
2021
Q3 		$990M Buy
7,804,300
+1,697,159
+28% +$247M 0.62% 23
2021
Q2 		$1.02B Buy
6,107,141
+1,323,274
+28% +$214M 0.6% 25
2021
Q1 		$869M Buy
4,783,867
+1,562,318
+48% +$362M 0.54% 28
2020
Q4 		$644M Buy
3,221,549
+1,927,001
+149% +$392M 0.42% 43
2020
Q3 		$284M Buy
1,294,548
+912,854
+239% +$193M 0.19% 118
2020
Q2 		$72.8M Buy
381,694
+174,585
+84% +$30.6M 0.05% 386
2020
Q1 		$32.1M Sell
207,109
-711,246
-77% -$82.7M 0.03% 551
2019
Q4 		$76.9M Sell
918,355
-122,972
-12% -$9.36M 0.06% 344
2019
Q3 		$70.5M Buy
1,041,327
+556,269
+115% +$36.6M 0.06% 335
2019
Q2 		$32.2M Buy
485,058
+318,538
+191% +$18.6M 0.03% 563
2019
Q1 		$9.26M Buy
+166,520
New +$10.2M 0.01% 693

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TDOC Position: Q3 2024 in Review

Sumitomo Mitsui Trust Group sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 4,136,936 shares — an estimated $40.5M sold.

Sumitomo Mitsui Trust Group first reported a position in TDOC in Q1 2019 and held it in 22 quarters. The position peaked at $1.02B in Q2 2021. 365 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Sumitomo Mitsui Trust Group reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 4,136,936 Teladoc Health shares in Q3 2024, an estimated $40.5M.
  • Sumitomo Mitsui Trust Group first reported a position in Teladoc Health in Q1 2019 and held it in 22 quarters.
  • Sumitomo Mitsui Trust Group's Teladoc Health position peaked at $1.02B in Q2 2021.
  • 365 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2024, filed 5 Nov 2024.